Stock NTLA INTELLIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Intellia Therapeutics, Inc.

Equities

NTLA

US45826J1051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
21.53 USD -1.37% Intraday chart for Intellia Therapeutics, Inc. +0.14% -29.39%
Apr. 15 Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer CI
Mar. 25 Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. NTLA Stock
  4. News Intellia Therapeutics, Inc.
  5. Official Publications